Revised U.S. Bill Impacts WuXi Shares: A Look at the Volatility
Monday, 13 May 2024, 05:28
WuXi Shares Volatile: U.S. Bill Sets Deadline for Decoupling
WuXi AppTec and its affiliates faced volatile trading due to the introduction of a revised version of the Biosecure Act by U.S. lawmakers. The bill proposes setting a deadline of 2032 for U.S. companies to sever ties with named Chinese biotech firms, leading to uncertainty in the market.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.